Published in Cancer Res on May 01, 1994
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55
Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer. Toxicol Pathol (2012) 0.84
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev (1984) 5.36
Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest (1983) 3.32
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest (1997) 2.48
Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today (1989) 2.47
Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon. Infect Immun (1984) 2.32
Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine (2000) 2.18
Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest (1991) 2.11
Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol (1993) 2.03
Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem (1986) 2.01
Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol (1997) 1.72
Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J Immunol (1987) 1.72
Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J Immunol (1988) 1.49
Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J Immunol (1997) 1.42
Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol (1996) 1.39
MLC-conditioned media stimulate an increase in Fc receptors on human macrophages. J Immunol (1981) 1.34
Increased proliferation of human synovial fibroblasts treated with recombinant immune interferon. J Immunol (1985) 1.33
Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology (1995) 1.33
Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J Immunol (1992) 1.31
Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol (1997) 1.31
Characteristics of lipocortin 1 binding to the surface of human peripheral blood leucocytes. Biochem Soc Trans (1990) 1.26
IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol (1998) 1.23
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest (1996) 1.23
The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII. J Immunol (1990) 1.19
Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand (2004) 1.19
Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ (1998) 1.13
Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol (1986) 1.11
Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J Immunol (1990) 1.10
IFN-gamma plus glucocorticoids stimulate the expression of a newly identified human mononuclear phagocyte-specific antigen. J Immunol (1988) 1.09
Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol (2002) 1.08
Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells. J Immunol (1993) 1.07
Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG. J Immunol (1986) 1.06
Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). J Immunol (1984) 1.05
Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol (1993) 1.03
Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood (1984) 1.01
Action potentials in macrophages derived from human monocytes. Science (1983) 1.01
Regulation of inflammation by lipocortin 1. Immunol Today (1992) 1.00
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J Immunol (2000) 1.00
Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol (1986) 0.99
Evidence for specific annexin I-binding proteins on human monocytes. Biochem J (1996) 0.97
Neutrophil activation through high-affinity Fc gamma receptor using a monomeric antibody with unique properties. Blood (1991) 0.95
Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol (1990) 0.95
Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J Immunol Methods (2001) 0.94
Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum (1992) 0.94
Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest (1984) 0.94
MHC class II expression and antigen presentation by human endometrial cells. J Steroid Biochem Mol Biol (2001) 0.93
Glucocorticoids enhance the gamma-interferon augmentation of human monocyte immunoglobulin G Fc receptor expression. J Immunol (1987) 0.92
Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors. Biochem Biophys Res Commun (1993) 0.91
Development of an ELISA to measure soluble CD163 in biological fluids. J Immunol Methods (2001) 0.91
Glucocorticoid enhances gamma interferon effects on human monocyte antigen expression and ADCC. Clin Exp Immunol (1986) 0.91
Bispecific antibodies. Crit Rev Immunol (1992) 0.90
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol (1995) 0.89
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells. Blood (1985) 0.89
Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis (1992) 0.89
Recombinant human immune interferon induces increased IgE receptor expression on the human monocyte cell line U-937. J Immunol (1984) 0.89
Glucocorticoid actions on the immune system: inhibition of production of an Fc-receptor augmenting factor. J Steroid Biochem (1981) 0.89
Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma. J Immunother Emphasis Tumor Immunol (1993) 0.89
F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J Clin Invest (1996) 0.88
Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody. J Immunol (1995) 0.87
Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood (1996) 0.87
Glucocorticoids inhibit IgE receptor expression on the human monocyte cell line U937. Immunology (1985) 0.86
Functional comparison of the inductions of NADPH oxidase activity and Fc gamma RI in IFN gamma-treated U937 cells. Mol Immunol (1990) 0.86
Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression. J Leukoc Biol (1997) 0.85
Mature polymorphonuclear leukocytes express high-affinity receptors for IgG (Fc gamma RI) after stimulation with granulocyte colony-stimulating factor (G-CSF). J Leukoc Biol (1995) 0.85
Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in pre- and post-menopausal women. Am J Reprod Immunol (1999) 0.84
Direct stimulation of ADCC by cloned gamma interferon is not ablated by glucocorticoids: studies using a human monocyte-like cell line (U-937). Mol Immunol (1984) 0.84
Differential expression of Fc receptors for IgG by monocytes and granulocytes from neonates and adults. Clin Exp Immunol (1996) 0.83
Fc gamma R in cytotoxicity exerted by mononuclear cells. Chem Immunol (1989) 0.82
Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J Biol Chem (1989) 0.81
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu. J Immunol Methods (2001) 0.80
Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes. Br J Haematol (1996) 0.80
Effect of low-density lipoprotein on the expression of high affinity Fc gamma receptors. Biochim Biophys Acta (1989) 0.80
Fc gamma RI blockade and modulation for immunotherapy. Cancer Immunol Immunother (1998) 0.79
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu. J Immunother (2001) 0.79
Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells. Cancer Res (1997) 0.79
Impairment of neutrophil Fc gamma receptor mediated transmembrane signalling in active rheumatoid arthritis. Ann Rheum Dis (1992) 0.79
Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). J Hematother (1992) 0.78
Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo. J Immunol Methods (2001) 0.78
Bispecific antibodies for targeted cellular cytotoxicity. Trends Biotechnol (1991) 0.78
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu. J Hematother (1995) 0.77
Fc gamma RII on human B cells can mediate enhanced antigen presentation. Cell Immunol (1996) 0.77
Ion channels in human macrophages compared with the U-937 cell line. J Membr Biol (1987) 0.77
Glucocorticoid actions on lymphoid tissue and the immune system: physiologic and therapeutic implications. Prog Clin Biol Res (1984) 0.77
Effect of morphine and beta-endorphin on human Fc receptor-dependent and natural killer cell functions. Clin Immunol Immunopathol (1992) 0.77
Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. J Leukoc Biol (1994) 0.77
Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines. Cancer Res (1988) 0.76
Single step screening of monoclonal antibodies against interferon-gamma-induced surface molecules on human monocytes. J Immunol Methods (1989) 0.75
Uptake of antigen-antibody complexes by human dendritic cells. Methods Mol Med (2001) 0.75
Spurious E rosette formation in B cell chronic lymphocytic leukemia due to monoclonal anti-sheep RBC antibody. Blood (1985) 0.75
Production and use of anti-FcR bispecific antibodies. Immunomethods (1994) 0.75
Major histocompatibility complex (B): effect on the response of chickens to a second challenge with rous sarcoma virus. Poult Sci (1982) 0.75
Use of bispecific antibodies in the therapy of tumors. Cancer Treat Res (1993) 0.75